tiprankstipranks
Tenaya Therapeutics (TNYA)
NASDAQ:TNYA
US Market
TNYA
Tenaya Therapeutics
RESEARCH TOOLSreports
Want to see TNYA full AI Analyst Report?

Tenaya Therapeutics (TNYA) Income Statement

3,235 Followers

Tenaya Therapeutics Income Statement

Last quarter (Q1 2026), Tenaya Therapeutics's total revenue was $225.00K, an increase of Infinity% from the same quarter last year. In Q1, Tenaya Therapeutics's net income was $-19.27M. See Tenaya Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ -8.44M$ -8.47M$ -8.69M$ -8.71M$ -4.03M
Operating Expenses
$ 84.89M$ 107.48M$ 122.51M$ 116.91M$ 68.78M
Depreciation and Amortization
$ 8.44M$ 8.47M$ 8.69M$ 8.71M$ 4.03M
EBITDA
$ -84.89M$ -102.66M$ -115.40M$ -114.95M$ -68.70M
Operating Income
$ -93.33M$ -115.95M$ -131.19M$ -125.62M$ -72.81M
Other Income/Expenses
$ 2.73M$ 4.82M$ 7.11M$ 1.96M$ 85.00K
Pretax Income
$ -90.60M$ -111.13M$ -124.08M$ -123.67M$ -72.72M
Net Income
$ -90.60M$ -111.13M$ -124.08M$ -123.67M$ -72.72M
Per Share Metrics
Basic EPS
$ -0.59$ -1.31$ -1.68$ -2.76$ -1.69
Diluted EPS
$ -0.59$ -1.31$ -1.68$ -2.76$ -1.69
Weighted Average Shares Outstanding
 152.97M 84.82M 73.79M 44.82M 41.29M
Weighted Average Shares Outstanding (Diluted)
 152.97M 84.82M 73.79M 44.82M 41.29M
Currency in USD

Tenaya Therapeutics Earnings and Revenue History